XM does not provide services to residents of the United States of America.
V
V

ViforPharma

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Redcare gains on Q3 beat

BUZZ-Redcare gains on Q3 beat ** Shares in Redcare Pharmacy RDC.DE rise around 3.7 % , pares gains after rising as much as 6.1%, after the online pharmacy retailer beats earning expectations in Q3, supported by a 67% growth in sales ** The co achieved an EBITDA including MediService AG of 15.2 million euros ($16.12 million), nearly double the company-compiled consensus of 7.9 million euros ** Redcare adj.
V

Redcare Pharmacy hits 1-1/2 year high on raised margin guidance

BUZZ-Redcare Pharmacy hits 1-1/2 year high on raised margin guidance Updates share move, adds Baader comment ** Shares in Redcare Pharmacy RDC.DE rise 12%, on track for best day since early January, after the online pharmacy beat Q2 EBITDA estimates and raised 2023 sales and margin guidance ** The stock touches its highest price since December 2021 at 119 euros per share ** The company sees non-prescription drug sales growth of 20-30%, up from 10-20%, and adj.
V

Redcare Pharmacy rises on EBITDA beat, outlook lift

BUZZ-Redcare Pharmacy rises on EBITDA beat, outlook lift ** Shares in Redcare Pharmacy RDC.DE are up 4% in early Frankfurt trade after the online pharmacy beat Q2 EBITDA estimates and raised 2023 sales and margin guidance ** Redcare reports Q2 adjusted EBITDA of 11.9 million euros ($13.1 million), excluding MediService AG; this was above consensus, according to a local trader ** The company sees non-prescription drug sales growth of 20-30%, up from 10-20%, and adj.
V

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.